These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1069 related items for PubMed ID: 27184254

  • 1. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
    Ribeiro JR, Schorl C, Yano N, Romano N, Kim KK, Singh RK, Moore RG.
    J Ovarian Res; 2016 May 17; 9(1):28. PubMed ID: 27184254
    [Abstract] [Full Text] [Related]

  • 2. [Chemotherapy resistance induced by interleukin-6 in ovarian cancer cells and its signal transduction pathways].
    Wang Y, Li LZ, Ye L, Niu XL, Liu X, Zhu YQ, Sun WJ, Liang YJ.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Sep 17; 45(9):691-8. PubMed ID: 21092551
    [Abstract] [Full Text] [Related]

  • 3. Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer.
    Lee S, Choi S, Lee Y, Chung D, Hong S, Park N.
    J Obstet Gynaecol Res; 2017 Jan 17; 43(1):220-227. PubMed ID: 27862665
    [Abstract] [Full Text] [Related]

  • 4. Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells.
    Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, Li LZ.
    Cancer Lett; 2010 Sep 01; 295(1):110-23. PubMed ID: 20236757
    [Abstract] [Full Text] [Related]

  • 5. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
    Li C, Ding H, Tian J, Wu L, Wang Y, Xing Y, Chen M.
    Cell Physiol Biochem; 2016 Sep 01; 39(1):242-52. PubMed ID: 27336949
    [Abstract] [Full Text] [Related]

  • 6. Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagy.
    He J, Yu JJ, Xu Q, Wang L, Zheng JZ, Liu LZ, Jiang BH.
    Autophagy; 2015 Sep 01; 11(2):373-84. PubMed ID: 25650716
    [Abstract] [Full Text] [Related]

  • 7. Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2.
    Xu L, Zhang B, Li W.
    Mol Med Rep; 2021 Apr 01; 23(4):. PubMed ID: 33576437
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J, Wang Q, Zhang W, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr 25; 51(4):285-92. PubMed ID: 27116987
    [Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway.
    Zhang C, Wang M, Shi C, Shi F, Pei C.
    Biosci Trends; 2018 Jul 17; 12(3):309-316. PubMed ID: 29952351
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of SOX2 is involved in paclitaxel resistance of ovarian cancer via the PI3K/Akt pathway.
    Li Y, Chen K, Li L, Li R, Zhang J, Ren W.
    Tumour Biol; 2015 Dec 17; 36(12):9823-8. PubMed ID: 26159849
    [Abstract] [Full Text] [Related]

  • 12. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L, Lai D, Liu T, Cheng W, Guo L.
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep 17; 42(9):593-602. PubMed ID: 20705681
    [Abstract] [Full Text] [Related]

  • 13. [Inhibition of Topo II alpha gene expression and reversing of drug resistance in multi-drug resistant epithelial ovarian cancer cells induced by RNA interference in vitro].
    He J, Li L, Tang BJ, Zhang W, Li DR, Wang Q.
    Zhonghua Fu Chan Ke Za Zhi; 2009 Sep 17; 44(9):686-90. PubMed ID: 20079182
    [Abstract] [Full Text] [Related]

  • 14. Time-staggered inhibition of JNK effectively sensitizes chemoresistant ovarian cancer cells to cisplatin and paclitaxel.
    Seino M, Okada M, Sakaki H, Takeda H, Watarai H, Suzuki S, Seino S, Kuramoto K, Ohta T, Nagase S, Kurachi H, Kitanaka C.
    Oncol Rep; 2016 Jan 17; 35(1):593-601. PubMed ID: 26534836
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of p27Kip1 by demethylation sensitizes cisplatin-resistant human ovarian cancer SKOV3 cells.
    Zhao Y, Li Q, Wu X, Chen P.
    Mol Med Rep; 2016 Aug 17; 14(2):1659-66. PubMed ID: 27314502
    [Abstract] [Full Text] [Related]

  • 16. Regulation of survival and chemoresistance by HSP90AA1 in ovarian cancer SKOV3 cells.
    Chu SH, Liu YW, Zhang L, Liu B, Li L, Shi JZ, Li L.
    Mol Biol Rep; 2013 Jan 17; 40(1):1-6. PubMed ID: 23135731
    [Abstract] [Full Text] [Related]

  • 17. [Suppression of WWOX gene by RNA interference reverses platinum resistance acquired in SKOV3/SB cells].
    Liu YY, Li L, Li DR, Zhang W, Wang Q.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Nov 17; 43(11):854-8. PubMed ID: 19087571
    [Abstract] [Full Text] [Related]

  • 18. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
    Li C, Ding H, Tian J, Wu L, Wang Y, Xing Y, Chen M.
    Cell Physiol Biochem; 2016 Nov 17; 39(3):1098-110. PubMed ID: 27562816
    [Abstract] [Full Text] [Related]

  • 19. Differential activation of NF-κB signaling is associated with platinum and taxane resistance in MyD88 deficient epithelial ovarian cancer cells.
    Gaikwad SM, Thakur B, Sakpal A, Singh RK, Ray P.
    Int J Biochem Cell Biol; 2015 Apr 17; 61():90-102. PubMed ID: 25681684
    [Abstract] [Full Text] [Related]

  • 20. Human epididymis protein 4 inhibits proliferation of human ovarian cancer cells via the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways.
    Kong X, Chang X, Cheng H, Ma R, Ye X, Cui H.
    Int J Gynecol Cancer; 2014 Mar 17; 24(3):427-36. PubMed ID: 24557433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.